Workers Compensation  |  Pharmacy Reviews  |  Best Practice

Not all medication reviews are the same. In Workers’ Compensation, the stakes are high: a poorly managed medication regime can delay return to work, create dependency, and significantly inflate claim costs. The best reviews go well beyond a basic script check.

This article outlines what separates an average medication review from a genuinely useful one, what to look for in a provider, and the outcomes that best-practice reviews actually achieve.

What Makes a Medication Review Genuinely Useful in WC?

A meaningful pharmacy review for a Workers’ Compensation claim should do more than list what a claimant is taking. The most valuable reviews share five characteristics:

  • Independence: The reviewer must have no financial relationship with the treating prescriber or the pharmacy supplying the medications. Conflict of interest, even perceived, undermines the credibility of recommendations.
  • Clinical depth: Reviews should cover all medications, not just those directly related to the claim. Non-claim medications frequently interact with claim-related prescriptions in ways that affect sedation, cognition, and physical capacity.
  • Plain-English reporting: Reports written in dense clinical language are difficult for case managers to act on. The best reviews produce clear, prioritised recommendations that non-clinicians can understand and use.
  • Prescriber engagement: A review that sits in a file and is never acted on has limited value. Providers with high prescriber engagement rates demonstrate that their recommendations are credible and well-reasoned.
  • Return-to-work alignment: Medication management should always be viewed through the lens of recovery and work capacity. Reviews that assess how the medication regime affects a worker’s ability to perform duties provide far more strategic value.

The IMM Standard: Evidence-Based Pharmacy Review for WC

Independent Med Management (IMM) was established specifically to address the gap between clinical pharmacy expertise and the practical needs of Workers’ Compensation insurers. IMM reviews are conducted by accredited clinical pharmacists with direct experience in the WC environment.

IMM Review Coverage
  • All claim-related and non-claim-related medications
  • Drug interactions, contraindications, and duplicated therapy
  • Appropriateness of dose, duration, and indication for each medication
  • High-risk categories: opioids, benzodiazepines, z-drugs, antidepressants, sedating antihistamines
  • Return-to-work impact assessment
  • Titration and deprescribing recommendations where appropriate
  • Communication with treating GP where clinically indicated

What the Data Shows

IMM publishes outcome data from its reviews because transparency matters. The results below reflect real-world outcomes from pharmacy reviews conducted across Australian WC claims:

81%
Prescriber implementation rate
43%
Opioid cessation success rate
36%
Benzodiazepine cessation success rate
50%
Antidepressant reduction success rate

The 81% prescriber implementation rate is particularly significant. It means that in the vast majority of cases, the treating GP acts on IMM’s recommendations. This reflects the clinical quality of the reviews and the respectful, collegial tone in which they are communicated.

Focus Areas: High-Risk Medication Categories

Workers’ Compensation claims disproportionately involve medications with significant dependency and sedation risk. Best-practice reviews pay particular attention to:

Opioids

Long-term opioid prescribing in WC is common but often counterproductive. Evidence consistently shows that prolonged opioid use for musculoskeletal injury does not improve functional outcomes and is associated with delayed return to work, increased psychological comorbidity, and dependency. A rigorous review will assess whether opioid prescribing is clinically justified, identify safer alternatives, and develop a realistic titration plan.

Benzodiazepines and Z-Drugs

Sedative hypnotics including benzodiazepines (diazepam, oxazepam, clonazepam) and z-drugs (zolpidem, zopiclone) are commonly prescribed for sleep and anxiety in WC claimants. These medications carry significant risks including cognitive impairment, falls, and dependency. Long-term use is rarely appropriate and reviews should assess the feasibility of gradual dose reduction.

Antidepressants

Antidepressants are widely used in WC for pain, sleep, and mood. While appropriate in some circumstances, they are frequently continued beyond the recommended duration without review. Sedating antidepressants in particular can significantly impair work capacity.

Aligning Reviews with Australian Scheme Guidelines

IMM reviews are conducted in alignment with:

  • SIRA NSW Guidelines for the Management of Acute Whiplash Associated Disorders and other relevant clinical frameworks
  • RACGP and Australian Pain Society guidance on opioid prescribing
  • TGA requirements including relevant clinical information sheets
  • State-specific return-to-work legislative frameworks

This alignment ensures that recommendations are defensible, clinically grounded, and consistent with the regulatory environment the insurer operates in.

How to Choose the Right Provider

When evaluating a medication review provider for your WC claims, consider asking:

  • What are your prescriber implementation rates? This is the most meaningful measure of clinical credibility.
  • Do your reviewers have WC-specific experience? Pharmacy review for insurance is a specialist field. Generalist pharmacists may lack the claims context to produce actionable recommendations.
  • How are reports communicated to treating doctors? A review that is posted in a file and never actioned has no value. Ask about GP communication protocols.
  • What is the turnaround time? Complex claims require timely information. Two to five business days is a reasonable benchmark.
  • Can reviews be escalated? Some claims require follow-up reviews or pharmacist-to-GP calls. Check whether these are available.

Summary

The best medication reviews for Workers’ Compensation are independent, clinically rigorous, plainly communicated, and oriented toward recovery and return to work. They focus on high-risk medication categories, engage prescribers constructively, and produce outcomes that are measurable.

IMM was built for exactly this purpose. If medication management is a concern on your claim, an IMM review is the most direct path to clarity and action.

IMM: Australia’s Medication Risk Governance Specialists

Jurisdiction: All major Australian WC schemes including icare NSW, WorkCover QLD, WorkSafe VIC, ReturnToWorkSA, and Comcare

Turnaround: 2 to 5 business days from receipt of records

Output: Clinical report with risk classification and prioritised recommendations

Contact: imedmanagement.com.au

Independent Med Management (IMM) provides pharmacy review and medication risk governance services to Workers’ Compensation and CTP insurers across Australia. This article is for general information purposes. Clinical decisions should be made in consultation with qualified health professionals.

Evidence-Based Medication Oversight for Better Claim Outcomes

Expert pharmacy reviews and medication management services that help claims teams make confident, informed decisions about medication-related claims.

Got Questions? Speak to an Independent Pharmacist

Unbiased advice on your claimant's medications and recovery plan.